Brokerages Set Envision Healthcare Co. (EVHC) Target Price at $65.33

Shares of Envision Healthcare Co. (NYSE:EVHC) have earned an average recommendation of “Buy” from the sixteen analysts that are presently covering the company. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation, ten have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $75.86.

Several analysts have recently issued reports on the company. Cantor Fitzgerald reaffirmed a “buy” rating and set a $80.00 price objective on shares of Envision Healthcare in a report on Thursday, April 6th. Jefferies Group LLC reaffirmed a “buy” rating and set a $82.00 price objective (down from $90.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. Canaccord Genuity reaffirmed a “buy” rating and set a $86.00 price objective on shares of Envision Healthcare in a report on Tuesday. Royal Bank of Canada decreased their price objective on Envision Healthcare from $87.00 to $80.00 and set an “outperform” rating on the stock in a report on Wednesday, March 1st. Finally, Zacks Investment Research raised Envision Healthcare from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a report on Wednesday, February 1st.

TRADEMARK VIOLATION NOTICE: This story was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.chaffeybreeze.com/2017/04/20/brokerages-set-envision-healthcare-co-evhc-target-price-at-65-33-updated-updated.html.

In related news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $65.00, for a total transaction of $97,500.00. Following the sale, the insider now owns 104,319 shares in the company, valued at approximately $6,780,735. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.30% of the company’s stock.

A number of institutional investors have recently made changes to their positions in EVHC. Morgan Stanley increased its position in shares of Envision Healthcare by 506.4% in the third quarter. Morgan Stanley now owns 6,715,363 shares of the company’s stock valued at $149,551,000 after buying an additional 5,608,016 shares during the period. Valinor Management L.P. increased its position in shares of Envision Healthcare by 16.6% in the third quarter. Valinor Management L.P. now owns 5,234,911 shares of the company’s stock valued at $116,582,000 after buying an additional 746,888 shares during the period. BlackRock Institutional Trust Company N.A. increased its position in shares of Envision Healthcare by 1.2% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 4,925,792 shares of the company’s stock valued at $109,697,000 after buying an additional 58,376 shares during the period. Artisan Partners Limited Partnership increased its position in shares of Envision Healthcare by 42.6% in the fourth quarter. Artisan Partners Limited Partnership now owns 3,958,470 shares of the company’s stock valued at $250,532,000 after buying an additional 1,182,329 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Envision Healthcare by 160.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,835,274 shares of the company’s stock valued at $179,458,000 after buying an additional 1,747,904 shares during the period. 35.96% of the stock is currently owned by institutional investors.

Shares of Envision Healthcare (NYSE:EVHC) traded down 3.60% on Tuesday, hitting $55.39. 4,567,366 shares of the stock were exchanged. Envision Healthcare has a 52-week low of $53.12 and a 52-week high of $83.27. The company’s market cap is $6.44 billion. The company has a 50 day moving average of $62.93 and a 200 day moving average of $52.16.

Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings results on Tuesday, February 28th. The company reported $1.08 EPS for the quarter, missing the Zacks’ consensus estimate of $1.20 by $0.12. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. The business earned $1.39 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the prior year, the firm posted $1.07 earnings per share. The firm’s revenue for the quarter was up 97.4% on a year-over-year basis. Equities research analysts forecast that Envision Healthcare will post $1.40 earnings per share for the current year.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

5 Day Chart for NYSE:EVHC

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply